These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4419955)

  • 21. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
    Sultan Y; Brouet JC
    Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Factor-(8) concentrate in haemophilia.
    Cronin CA
    Lancet; 1975 Jun; 1(7919):1303. PubMed ID: 48938
    [No Abstract]   [Full Text] [Related]  

  • 23. Factor VIII concentrate available for treatment of classical hemophilia.
    Jewett WR
    Ann N Y Acad Sci; 1975 Jan; 240():188-90. PubMed ID: 1053863
    [No Abstract]   [Full Text] [Related]  

  • 24. Acquired hemophilia and its treatment.
    Sultan Y
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S15-8. PubMed ID: 9351531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acquired inhibitor hemophilia].
    Brackmann HH
    Pharm Unserer Zeit; 2006; 35(1):58-64. PubMed ID: 16465867
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of animal AHG concentrates (factor VIII) in the treatment of life-threatening hemorrhage in patients with factor VIII antibodies.
    Rubin R; Niemetz J; Estren S
    Ann N Y Acad Sci; 1975 Jan; 240():362-9. PubMed ID: 1053881
    [No Abstract]   [Full Text] [Related]  

  • 27. Highly purified porcine factor VIII in haemophilia A.
    Hewitt P; Mackie IJ; Machin SJ
    Lancet; 1982 Mar; 1(8274):741-2. PubMed ID: 6122035
    [No Abstract]   [Full Text] [Related]  

  • 28. Recombinant factor VIII concentrate. The MSAC, Canadian Hemophilia Society. Canadian Hemophilia Clinic Directors Group.
    Walker I; Poon MC
    Lancet; 1992 Jan; 339(8784):61-2. PubMed ID: 1345984
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemophilia: acquired modifications of the genetic disorder.
    Hampton JW; Warner D
    Ann N Y Acad Sci; 1975 Jan; 240():405-6. PubMed ID: 1053884
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemophilia A prophylaxis with factor VIII concentrate in a home-treatment program: a controlled study.
    Schimpf K; Fischer B; Rothmann P
    Scand J Haematol Suppl; 1977; 30():79-80. PubMed ID: 327532
    [No Abstract]   [Full Text] [Related]  

  • 31. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A.
    Hsu HC; Chen YF; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):450-4. PubMed ID: 10418180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of factor VIII in hemophilia.
    Lacroix-Desmazes S; Dimitrov JD; Repesse Y
    N Engl J Med; 2009 Jul; 361(3):308; author reply 310. PubMed ID: 19605840
    [No Abstract]   [Full Text] [Related]  

  • 33. [Recombinant factor VIII concentrate].
    Fukutake K
    Rinsho Byori; 1992 Mar; Suppl 92():94-106. PubMed ID: 1583781
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of patients with hemophilia A having antibodies to factor VIII].
    Lopaciuk S; Ziemski JM
    Acta Haematol Pol; 1979; 10(2):115-22. PubMed ID: 474044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Importance of corticoids in inhibitor suppression in hemophilia A, in addition to continuing treatment with factor VIII concentrate].
    Aznar JA; Jorquera JI; Marty ML
    Sangre (Barc); 1983; 28(3):265-79. PubMed ID: 6414098
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemophilia, antihemophilic factor, and immune complexes.
    Kimberly RP; Bussel JB; Hilgartner MW
    Ann Intern Med; 1984 Jun; 100(6):915-6. PubMed ID: 6426361
    [No Abstract]   [Full Text] [Related]  

  • 37. Factor VIII inhibitors in hemophilia.
    Mariani G
    Bilt Hematol Transfuz; 1979; 7(1):3-41. PubMed ID: 121880
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inhibitors against factor VIII in hemophilia. A review of treatment possibilities and personal results].
    Scheibel E; Feddersen C
    Ugeskr Laeger; 1985 Nov; 147(47):3803-7. PubMed ID: 3934824
    [No Abstract]   [Full Text] [Related]  

  • 39. [Advances in hemophilia treatment: a hepatitis-safe factor VIII concentrate].
    Heimburger N
    Blut; 1982 Apr; 44(4):249-51. PubMed ID: 6805537
    [No Abstract]   [Full Text] [Related]  

  • 40. Desensitization to factor VIII in a patient with classic hemophilia and C2 deficiency.
    Jamieson DM; Stafford CT; Maloney MJ; Lutcher CL
    Ann Allergy; 1987 Mar; 58(3):215-20. PubMed ID: 3103496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.